Bal Pharma Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 66.38 | 82.77 | 73.39 |
| Operating Expense | 59.48 | 73.95 | 64.95 |
| Net Profit | 0.32 | 5.61 | 0.69 |
| Net Profit Margin | 0.48 | 6.78 | 0.94 |
| Earning Per Share | 0.20 | 3.51 | 0.73 |
| EBIDTA | 6.89 | 10.32 | 8.53 |
| Effective Tax Rate | TBA | -14.74 | 1.66 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 66.38 |
| Operating Expense | 59.48 |
| Net Profit | 0.32 |
| Net Profit Margin | 0.48 |
| Earning Per Share | 0.20 |
| EBIDTA | 6.89 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 302.50 | 338.54 | 303.10 |
| Operating Expenses Annual | 272.42 | 307.01 | 276.80 |
| Operating Profit Annual | 32.23 | 33.83 | 28.49 |
| Interest Annual | 16.85 | 14.46 | 12.46 |
| Depreciation | 6.06 | 6.13 | 5.52 |
| Net Profit Annual | 7.80 | 7.73 | 6.13 |
| Tax Annual | -2.07 | 1.59 | 2.42 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 302.50 |
| Operating Expenses Annual | 272.42 |
| Operating Profit Annual | 32.23 |
| Interest Annual | 16.85 |
| Depreciation | 6.06 |
| Net Profit Annual | 7.80 |
| Tax Annual | -2.07 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 4.06 | 1.30 | 0.81 |
| Cash Flow from Operations | 20.31 | 28.54 | 5.38 |
| Cash Flow from Investing | -14.90 | -18.84 | -22.08 |
| Cash Flow from Financing | -7.83 | -6.94 | 17.12 |
| Cash Flow at the End | 1.64 | 4.06 | 1.23 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 4.06 |
| Cash Flow from Operations | 20.31 |
| Cash Flow from Investing | -14.90 |
| Cash Flow from Financing | -7.83 |
| Cash Flow at the End | 1.64 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 10.72 | 10.05 | 9.44 |
| PBIT Margin (%) | 7.53 | 7.08 | 6.97 |
| PBT Margin (%) | 7.09 | 6.60 | 6.42 |
| Net PROFIT Margin (%) | 2.58 | 2.28 | 2.02 |
| Return On Networth / Equity (%) | 8.14 | 8.19 | 6.69 |
| Return On Networth /Employed (%) | 9.42 | 10.41 | 10.08 |
| Return On Assets (%) | 3.22 | 3.36 | 2.91 |
| Total Debt / Equity (X) | 1.45 | 1.37 | 1.22 |
| Asset Turnover Ratio (%) | 1.25 | 1.47 | 1.44 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 10.72 |
| PBIT Margin (%) | 7.53 |
| PBT Margin (%) | 7.09 |
| Net PROFIT Margin (%) | 2.58 |
| Return On Networth / Equity (%) | 8.14 |
| Return On Networth /Employed (%) | 9.42 |
| Return On Assets (%) | 3.22 |
| Total Debt / Equity (X) | 1.45 |
| Asset Turnover Ratio (%) | 1.25 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 86.77 | 79.38 | 63.07 |
| Total Current Assets Annual | 247.65 | 246.55 | 269.95 |
| Non Current Assets Annual | 102.91 | 87.68 | 77.75 |
| Total Shareholders Funds Annual | 98.82 | 92.84 | 96.03 |
| Total Assets Annual | 350.56 | 334.23 | 347.70 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 86.77 |
| Total Current Assets Annual | 247.65 |
| Non Current Assets Annual | 102.91 |
| Total Shareholders Funds Annual | 98.82 |
| Total Assets Annual | 350.56 |
EPS (INR)
Expected
0.13
Reported
0.13
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by -0.29%
Sep 2024
EPS beaten by 10.00%
